UPPSALA, Sweden

Jörgen Höjdmo

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Raysearch Laboratories Ab (Publ). Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jörgen Höjdmo. Retrieved from https://idiyas.com/inventor/jörgen-höjdmo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jörgen Höjdmo: Innovator in Drug Concentration Evaluation

Introduction

Jörgen Höjdmo is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of drug evaluation through his innovative methods and systems. His work focuses on improving the accuracy of drug concentration measurements in body fluids.

Latest Patents

Höjdmo holds a patent for a "Method and system for evaluation of drug concentration in blood, plasma or serum." This patent describes a method that includes preparing body fluid samples by removing unsolved components, performing absorption spectrophotometric analyses, and evaluating drug concentrations based on these analyses. This innovative approach enhances the reliability of drug concentration assessments in clinical settings.

Career Highlights

Throughout his career, Jörgen Höjdmo has worked with prominent companies such as Raysearch Laboratories AB and Pharmacolog in Uppsala. His experience in these organizations has allowed him to develop and refine his patented methods, contributing to advancements in medical technology.

Collaborations

Höjdmo has collaborated with professionals in his field, including Hans Dahlin. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Jörgen Höjdmo's contributions to drug concentration evaluation demonstrate his commitment to innovation in the medical field. His patented methods are poised to improve clinical practices and patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…